Q2 Solutions Medical Research Investment (Beijing) Co., Ltd. Co., Ltd., Covance R&D Co., Ltd. WuXi AppTec Co., Ltd Sun Q2 Shi Solutions Xiuli, Li Nivolumab Squibb KARL Tu Zhang 7 General / / University Medical Ping, Yu / / Injection (China) LINTEL Haiyan Li Hospital Cancer Research Investment Center (Beijing) Co., Ltd. Co., Ltd., Covance R&D Co., Ltd. Eisai Europe No.81 Ltd.; Quintiles Hospital Patheon Enterprise Mefenamic of the Inc.; Eisai JianGu Qin 8 acid Chinese / / / / / / XianSheng Shukui Yuekun capsules People's Limited; Liberation Eisai China Co., Ltd. Army Inc. Pfizer Peking Union Medical Zhang Pregabalin College 9 Wu Xiaobin / / / / / / / / Capsules Hospital, Deutschland Chinese GmbH, Academy of Freiburg;
Investment Co., Ltd. Q2 Solutions Medical Research (Beijing) Co., Ltd., Covance R&D Co., Ltd. 7 Nivolumab Injection Squibb (China) Investment Co., Ltd. KARL LINTEL General Hospital Tu Haiyan / / Sun University Cancer Center Zhang Li WuXi AppTec Co., Ltd Q2 Solutions Medical Research (Beijing) Co., Ltd., Covance R&D Co., Ltd. Shi Xiuli, Li Ping, Yu / / 8 Mefenamic acid capsules Eisai Europe Ltd.; Patheon Inc.; Eisai Limited; Eisai China Inc. JianGu XianSheng No.81 Hospital of the Chinese People's Liberation Army Qin Shukui Quintiles Enterprise Co., Ltd. Yuekun / / / / / / 9 Pregabalin Capsules Pfizer Deutschland GmbH, Freiburg; Wu Xiaobin Peking Union Medical College Hospital, Chinese Academy of Zhang / / / / / / / /